Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0249c8c96ed09a989cb0d43c51a3060d |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P13-002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C253-30 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-865 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02 |
filingDate |
2007-10-01^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c78055480ccf0ff1f248cc1a05d3d62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e65d5de44930bc69a4b1176c5add126 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98f28f1450ff9dd0609f6b96d05f142f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f3221841a8a6645bc188cfcdfb3aa05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29c36f4459a93eca1aa72a3ca80996af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1357afa61112ef501696247b1fca3f71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfc396a0ab40aac0fe50d1d6808a6647 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9bd2549769caab4e29a7e1745ec3b65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee9682e1ce9f52bca72ec8a63dba7635 |
publicationDate |
2009-08-04^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20090083900-A |
titleOfInvention |
Stereoisomerically pure statins and compositions for preparing synthetic intermediates thereof and methods of preparation |
abstract |
The present invention provides ketoductase enzymes having improved properties compared to naturally occurring wild type ketoductase enzymes. The invention also provides a method of using a polynucleotide encoding an engineered ketoductase enzyme, a host cell capable of expressing the engineered ketoductase enzyme, and an engineered ketoductase enzyme to synthesize a variety of pure compounds. And chiral pure compounds prepared therefrom. |
priorityDate |
2006-10-02^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |